As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...

If approved, AbbVie's Rinvoq could be set to dominate the alopecia market after exhibiting better efficacy than main ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Tyra Biosciences has dosed the first paediatric participant in the dose-escalation/dose-expansion Phase II BEACH301 trial of ...

UK-based Monument Therapeutics has joined forces with the Foundation for the National Institutes of Health (FNIH), US, to ...

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

Degrees Pharmaceuticals has entered into a clinical study agreement with the Icahn School of Medicine at Mount Sinai in the ...

The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Precision immunology company Scipher Medicine has introduced the ClinicalTrialRank.com AI platform to the public.

A recently published study provides an incentive to explore what specific aspects of vegetarianism are protective.